Tisotumab Vedotin + Carboplatin in First-Line or + Pembrolizumab in Previously Treated Recurrent/Metastatic Cervical Cancer: Interim Results of ENGOT-Cx8/GOG-3024/innovaTV 205

Vergote, I.B.; Monk, B.J.; O'Cearbhaill, R.E.; Westermann, A.M.; Banerjee, S.; Collins, D.C.; Mirza, M.R.; O'Malley, D.; GENNIGENS, Christine; Pignata, S.; Melichar, B.; Sadozye; Forget, F; Tewari, K.S.; Gort, E.; Soumaoro, I.; Mondrup Andreassen, C.; Nicacio, L.V.; Van Nieuwenhuysen, E.; Lorusso, D.

Poster (Scientific congresses and symposiums)

Vergote, I.B.; Monk, B.J.; O'Cearbhaill, R.E. et al.

2021 • Mini oral session - Gynaecological cancers

Permalink
https://hdl.handle.net/2268/264608

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

199-3107.pdf

Publisher postprint (502.13 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Tisotumab vedotin; Carboplatin (Carbo); Pembrolizumab (Pembro)

Disciplines :

Oncology

Author, co-author :

Vergote, I.B.

Monk, B.J.

O'Cearbhaill, R.E.

Westermann, A.M.

Banerjee, S.

Collins, D.C.

Mirza, M.R.

O'Malley, D.

GENNIGENS, Christine ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service d'oncologie médicale

Pignata, S.

More authors (10 more)

Language :

English

Title :

Tisotumab Vedotin + Carboplatin in First-Line or + Pembrolizumab in Previously Treated Recurrent/Metastatic Cervical Cancer: Interim Results of ENGOT-Cx8/GOG-3024/innovaTV 205

Publication date :

19 September 2021

Event name :

Mini oral session - Gynaecological cancers

Event organizer :

Ignace Vergote

Event date :

19 Sep 2021

Available on ORBi :

since 30 October 2021

Statistics

Number of views

81 (3 by ULiège)

Number of downloads

4 (4 by ULiège)

More statistics